Procter & Gamble Hygiene & Healthcare Ltd. - Research Center
500459 PGHH Group (A) BSE data
Add to watchlist
| Results |
Half yearly
|
| Statement | |
| More |
Half yearly results in brief
(Rs crore)
| Dec ' 24 | Dec ' 23 | Dec ' 22 | Jun ' 22 | Dec ' 21 | |
|---|---|---|---|---|---|
| Sales | 2,382.79 | 2,271.78 | 2,182.28 | 1,749.64 | 2,151.28 |
| Operating profit | 661.41 | 594.63 | 504.47 | 232.10 | 597.79 |
| Interest | 8.53 | 4.44 | 4.81 | 7.66 | 3.53 |
| Gross profit | 671.09 | 621.54 | 515.70 | 236.10 | 606.92 |
| EPS (Rs) | 148.03 | 135.43 | 111.48 | 44.79 | 132.58 |
Half yearly
results in details
| Dec ' 24 | Dec ' 23 | Dec ' 22 | Jun ' 22 | Dec ' 21 | |
|---|---|---|---|---|---|
| Other income | 18.21 | 31.35 | 16.04 | 11.66 | 12.66 |
| Stock adjustment | 5.70 | 23.27 | 10.73 | -13.04 | 6.54 |
| Raw material | 391.82 | 431.09 | 491.40 | 557.86 | 702.48 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 126.68 | 118.42 | 108.19 | 98.27 | 116.07 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | 280.17 | - | 209.26 | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 1,197.18 | 824.20 | 1,067.49 | 665.19 | 728.40 |
| Provisions made | - | - | - | - | - |
| Depreciation | 21.59 | 28.56 | 28.37 | 27.30 | 25.58 |
| Taxation | 169.01 | 153.39 | 125.45 | 63.40 | 150.99 |
| Net profit / loss | 480.49 | 439.59 | 361.88 | 145.40 | 430.35 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 32.46 | 32.46 | 32.46 | 32.46 | 32.46 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 27.76 | 26.17 | 23.12 | 13.27 | 27.79 |
| GPM (%) | 27.95 | 26.99 | 23.46 | 13.40 | 28.05 |
| NPM (%) | 20.01 | 19.09 | 16.46 | 8.26 | 19.89 |
© 2025 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis